M, E., D, W., S, P., C, H., D, B., & G, F. (2025). Compliance With FDA iCGM Special Controls is Dependent on Study Design and Procedures. Journal of diabetes science and technology, 19(3), 850. https://doi.org/10.1177/19322968251329879
Chicago Style (17th ed.) CitationM, Eichenlaub, Waldenmaier D, Pleus S, Haug C, Brandt D, and Freckmann G. "Compliance With FDA ICGM Special Controls Is Dependent on Study Design and Procedures." Journal of Diabetes Science and Technology 19, no. 3 (2025): 850. https://doi.org/10.1177/19322968251329879.
MLA (9th ed.) CitationM, Eichenlaub, et al. "Compliance With FDA ICGM Special Controls Is Dependent on Study Design and Procedures." Journal of Diabetes Science and Technology, vol. 19, no. 3, 2025, p. 850, https://doi.org/10.1177/19322968251329879.